Milk fever using calcium and phosphorus

Summary
Fifteen cows with milk fever were treated with 500 ml of 40 % calcium borogluconate (group A) administered intravenously. Fifteen other cows with milk fever received the same treatment, supplemented with 500 ml of 10 % sodium phosphate administered intravenously, and 80 g calcium as calcium lactate and 70 g inorganic phosphorus as sodium phosphate administered orally in drinking water. The cows were monitored and blood samples collected for 3 days to measure the concentrations of total and ionized calcium, inorganic phosphorus and magnesium and the activity of creatine kinase. The two groups did not differ signifi cantly with respect to the course of the disease. In each group 14 cows were cured. A rapid and signifi cant increase in serum calcium concentration from the hypo-to the hypercalcaemic range occurred in both groups within 10 min of the start of treatment, followed by a slow and steady decrease to the hypocalcaemic range. Calcium lactate did not prevent the calcium concentration from returning to the hypocalcaemic range, and the calcium profi les of the two groups did not differ signifi cantly. As expected, treatment had little effect on the concentration of inorganic phosphorus in group A. In group B, treatment caused a rapid increase in the concentration of inorganic phosphorus to a maximum 20 min after the start of treatment. This was followed by a slow decrease in the phosphorus concentration to the normophosphataemic range. Our fi ndings confi rmed that combined intravenous and oral administration of sodium phosphate in cows with periparturient paresis attributable to hypocalcaemia and hypophosphataemia results in a rapid and sustained increase in serum phosphorus, but not in serum calcium concentration. This modifi ed therapy did not improve the success rate of milk fever treatment and further studies are needed to improve treatment of periparturient paresis.
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Intravenöse und perorale Behandlung von Gebärparese-Kühen mit Kalzium und Phosphor
In der vorliegenden Untersuchung wurden 15 an Gebärparese erkrankte Kühe mit 500 ml einer 40 %igen Kalziumboroglukonatlösung intravenös (Gruppe A) behandelt. Weitere 15 Kühe (Gruppe B), die ebenfalls an Gebärparese erkrankt waren, erhielten die gleiche Behandlung und zusätzlich 500 ml einer 10 %igen Natriumdihydrogenphosphatlösung, ebenfalls intravenös. 
Introduction
The pathogenesis, prophylaxis and treatment of milk fever (parturient paresis) in dairy cows have recently been discussed in several review articles (Thilsing-Hansen et al., 2002; DeGaris and Lean, 2008; Goff, 2008; Murray et al., 2008) . Routine treatment of milk fever consists of intravenous administration of a calcium solution (Radostits et al., 2007) . The percentage of hypocalcaemic cows that respond to a single treatment ranges from 47 % (Salis, 2002; Braun et al., 2004) to 76 % (Malz and Meier, 1992) . Some cows relapse and require a second treatment, while others remain recumbent and are euthanized despite multiple treatments. Several studies carried out in our Clinic were aimed at improving the success rate of milk fever treatment. Modifi cations of routine treatment included the intravenous administration of calcium over several hours via an indwelling catheter (Salis, 2002; Braun et al., 2004a Braun et al., , 2004b , doubling the dose of calcium (Jehle, 2004; Braun et al., 2006) and supplementing the routine treatment with sodium phosphate administered either orally (Dumelin, 2005; Braun et al., 2007) or intravenously (Zulliger, 2008; Braun et al., 2009 ). However, none of these treatments improved the success rate compared with routine intravenous administration of calcium alone. None of these treatments led to a rapid increase and sustained elevation (48 -72 hours) of serum calcium and inorganic phosphorus concentrations that lasted 48 to 72 hours. The goal of the present study was to investigate whether the combination of various treatment modifi cations that had a positive therapeutic effect improved the overall outcome of milk fever treatment. To achieve this, initial intravenous treatment with calcium (Dumelin, 2005; Braun et al., 2007; Zulliger, 2008; Braun et al., 2009 ) and phosphorus (Dumelin, 2005; Braun et al., 2007) was followed immediately by oral administration of sodium phosphate (Zulliger, 2008; Braun et al., 2009 ). In addition, calcium lactate dissolved in water was provided for the cows in an attempt to stabilize the blood calcium concentration (Geishauser et al., 2008) .
Animals, Material and Methods
Animals
Thirty cows from 22 different clients of the ambulatory Clinic of the Department of Farm Animals, University of Zurich, were used. The patients were 4 to 10 years old (mean ± sd = 7.4 ± 1.54 years) and included 15 Simmental, 10 Swiss Braunvieh and 5 Holstein Friesian cows. Lactation numbers ranged from 3 to 8 (5.5 ± 1.43) and milk production of the previous lactation was 5400 to 12'000 kg (8043 ± 1613 kg). All cows had periparturient paresis within 24 hours of calving. Fourteen cows had milk fever during a previous lactation. Eighteen of the cows were treated prophylactically before signs of hypocalcaemia occurred using oral calcium products, which were administered immediately before or after parturition and in some cases combined with the intramuscular injection of vitamin D3 between 3 and 8 days before the anticipated date of calving. Light manual traction was used to deliver 8 of the calves, and 3 cows had a retained placenta. Treatment was started 1 to 10 hours (3.4 ± 1.99 hours) after periparturient paresis was diagnosed; this interval did not differ among the various treatment groups.
Clinical examination and diagnosis
The clinical examination included assessment of the demeanour and general condition, appetite, defaecation and micturition, rectal temperature, heart and respiratory rates, rumen motility, intestinal sounds, body posture, behavior, level of consciousness and sensitivity in the hind limbs. In addition, transrectal, vaginal and udder examinations including a California mastitis test were carried out. A urine sample was collected immediately before treatment and examined for acetoacetic acid (Keto-Diastix®, Bayer Consumer Care AG, Basel). The clinical fi ndings have been described in detail (Blatter, 2011) . A diagnosis of parturient paresis was made when clinical signs typical of this condition (Radostits et al., 2007) occurred within 24 hours after parturition.
Treatment
The cows were alternately assigned to group A or B depending on treatment. Both groups consisted of 15 cows that received 500 ml of a solution containing 40 % calcium borogluconate (15.65 g calcium gluconate and calcium borogluconate) and 6 % magnesium hypophosphite (9.85 g magnesium hypophosphite) (Calcamyl-40MP, Gräub, Bern) via an indwelling jugular vein catheter. Treatment was given slowly during 10 minutes and the heart rate was monitored continuously. Immediately after treatment with calcium, cows of group B received 500 ml of a 10 % solution of sodium phosphate (NaH2PO4 * 2 H2O, Streuli, Uznach), yielding 10 g of inorganic phosphorus, which was also given slowly during 10 minutes. After the second infusion, cows of group B were offered 20 litres of water containing calcium lactate to provide 80 g calcium (Propeller Calcium Drink®, Provet, Lyssach). Water that was refused was administered via stomach tube 10 minutes later. Then 350 g sodium phosphate (NaH2PO4 * 2 H2O, Streuli), yielding 70 g of inorganic phosphorus, was administered via stomach tube to all cows of group B. The hind legs were hobbled before treatment and the cows were rolled onto the other side. The cows were then monitored for 8 hours and futile and successful attempts to rise were noted. The demeanour and general condition, heart and respiratory rates, rectal temperature, rumen motility, appetite and defaecation were assessed hourly.
Follow-up treatment of non-responding and relapsing cows
Cows that did not respond to treatment within 8 hours or that relapsed were treated a second time with 500 ml of 40 % calcium borogluconate (300 ml were given intravenously and 200 ml subcutaneously). Cows that did not respond to the initial treatment received a second treatment with 500 ml of 40 % calcium borogluconate (300 ml were given intravenously and 200 ml subcutaneously) eight hours later. Cows that went down again received 500 ml calcium borogluconate intravenously at the time of the relapse.
Serum electrolytes and creatine kinase
Blood samples were collected from all cows into evacuated tubes without anticoagulant (Vacuette® Serum Sep. Clot Activator, 5 ml, Greiner bio-one GmbH, Kremsmünster, Austria) immediately before treatment and 10, 20, 40, 60 and 90 min and 2, 3, 4, 5, 6, 7, 8, 24, 48 and 72 hours after the start of treatment. The concentrations of total and ionized calcium, inorganic phosphorus and magnesium and the activity of creatine kinase (CK) were measured in serum. Ionised calcium was measured using an ion-selective electrolyte analyser (Nova CRT 8, Nova Biomedical, Germany) and the remaining variables were measured using a Cobas Integra 700 Analyzer (Roche Diagnostics, Rotkreuz) using the manufacturer's reagents (Roche-Reagents) according to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) at 37 °C.
Statistics
The data were analyzed using Stata (StataCorp., 2009; Stata Statistical Software: Release 11.0; College Station, Texas, USA). The frequencies, means and standard deviations were calculated. The clinical fi ndings and electrolyte concentrations of the cows of the two groups before treatment were compared using a chi-squared test for association and a two-sided Student's t test, respectively. Differences between the electrolyte concentrations in the two groups after treatment were analyzed using the Bonferroni/Dunn test. The response to treatment was analyzed in three different ways. A general linear model (GLM, <xtmixedvar1var2time || time:>) was used to analyze the differences between the clinical variables (demeanour, rectal temperature, superfi cial body temperature, ruminal motility, defaecation) before and after treatment within and among the groups. The numbers of cows that stood by 8, 24, 48 and 72 hours after treatment were compared among the time points and between the two groups. The various outcomes (cured after one treatment, cured after more than one treatment, relapsed after standing, unable to stand) were calculated and the results of the groups compared. The signifi cance of correlation coeffi cients was analyzed using the r to z test.
Results
Clinical fi ndings before treatment
The clinical fi ndings before treatment did not differ between the groups and they are therefore analyzed together. Eight cows had a normal demeanour, 16 were listless, 4 were somnolent and 2 were comatose. The latter 6 cows were in lateral recumbency and the remaining 24 were in sternal recumbency. The rectal temperature ranged from 35.6 to 39.8 °C (38.1 ± 0.86 °C) and the body surface of 27 cows was cold to the touch. Twenty-nine cows were anorexic and one ate very little. Ruminal motility was reduced in 3 cows and absent in 27. Intestinal atony occurred in 29 cows and 19 cows had dry hard faeces. Two cows had low levels of ketones in the urine.
Clinical fi ndings after treatment and outcome
There was no difference between the two groups with respect to outcome of treatment. Awareness normalized in all cows following treatment. Of the 6 cows that were stuporous before treatment, 4 were still mildly listless one hour after treatment. The rectal temperature normalized in all cows within 1 hour and the appetite normalized in 15 cows within 8 hours. Of the remaining 15 cows, 14 were still anorexic 8 hours after the start of treatment and one had a reduced appetite. Ruminal motility resumed within 1 hour in all cows. A total of 22 cows (73,3 %), 11 from each group, stood within 8 hours of treatment (Tab. 1) and 11 of these (3 from group A and 8 from group B) relapsed between 8 and 24 hours after the initial treatment. Thus, 8 cows of group A and 3 of group B were cured after one treatment. The 11 cows that relapsed after successful initial treatment and the 8 cows that did not respond to initial treatment were treated two to six times. The overall success rate did not differ between the two groups (14 of 15 cows were cured in each). 
Electrolyte concentrations before treatment
The electrolyte concentrations before treatment did not differ between the two groups. All cows had hypocalcaemia with concentrations of total calcium lower than 2.0 mmol/l and concentrations of ionized calcium lower than 1.15 mmol/l. There was also hypophosphataemia in all cows with concentrations of inorganic phosphorus lower than 1.30 mmol/l. The magnesium concentrations ranged from 0.81 to 1.84 mmol/l (normal range, 0.80 -1.20 mmol/l).
Electrolyte concentrations after treatment
Mean serum calcium concentrations increased rapidly and signifi cantly, and within 10 min after the start of treatment reached the hypercalcaemic range in both groups (Fig. 1) . After the peak the calcium concentration decreased gradually. Hypercalcaemia lasted 60 to 90 min, which was followed by normocalcaemia for 4 to 6 hours. Five to 7 hours after the start of treatment, the mean serum calcium concentration returned to the hypocalcaemic range, where it remained until 48 hours in both groups. The cows were normocalcaemic at 72 hours. The post-treatment profi les of total calcium differed signifi cantly between the two groups. At 8 hours, seven cows of group A and 14 cows of group B had hypocalcaemia (P < 0.01) (Tab. 2). Hypocalcaemia occurred in 9 cows of group A and 12 cows of group B at 24 hours post treatment (difference P < 0.01). The concentrations of ionized and total calcium were highly correlated (0.90 ≤ r ≤ 0.99, P ≤ 0.01) during the entire observation period, and the post-treatment profi les of ionised calcium did not differ between the two groups (Fig. 2) . The profi les of ionized and total calcium concentrations were similar. After treatment, cows of group A only had a slight increase in inorganic phosphorus compared with cows of group B (Fig. 3) . In group B, the mean concentration of inorganic phosphorus increased rapidly after treatment and at 20 min reached a maximum of 3.79 ± 1.23 mmol/l. The concentration then decreased slowly to the normophosphataemic range, where it remained for the remainder of the study period. The profi les of inorganic phosphorus differed signifi cantly between the two groups (P < 0.01). There was no difference between the two groups with respect to the proportion of cows that were hypophosphataemic at various time points (Tab. 2). The profi les of the magnesium concentrations of the two groups did not differ. In both groups, the magnesium concentration increased rapidly and signifi cantly (P < 0.05) within 10 min after the start of treatment (Fig. 4) , which was followed by a gradual decrease to pre-treatment concentrations 3 to 4 hours later.
Treatment outcome in relation to electrolyte concentrations and CK activity
The calcium profi le of the 22 cows that stood within 8 hours of treatment did not differ signifi cantly from the profi le of the eight cows that did not stand. In contrast, the cows that stood had signifi cantly higher phosphorus profi les than the cows that did not stand (P < 0.05). The cows that remained recumbent 8 hours after treatment had higher serum CK activity at 2 hours after treatment than the cows that stood (P < 0.05).
Discussion
In this study, two different treatments for milk fever were compared in 30 dairy cows. One treatment consisted of a standard intravenous calcium borogluconate infusion and the other combined intravenous infusion and oral administration of both calcium and phosphorus. Eleven of 15 cows in each group (73,3 %) stood within 8 hours of treatment, which was similar to success rates (70.0 and 73,5 %) reported in our previous studies (Salis, 2002; Braun et al., 2004a; Jehle, 2004; Dumelin, 2005; Braun et al., 2006; Braun et al., 2007) . In agreement with the previous results, the pre-treatment electrolyte concentrations were not related to the treatment outcome assessed 8 hours after treatment in the present study. The cows that did not stand within 8 hours received additional treatments. Cows that responded to treatment within 8 hours had signifi cantly higher serum phosphorus concentrations than cows that did not, which confi rmed previous suggestions that the post-treatment phosphorus profi le has prognostic value (Goff, 2000) . Eleven of 30 cows (37 %) had a favourable response to treatment initially, but relapsed later. The recurrence rate was considerably lower in previous studies at 3,7 % (Zulliger, 2008; Braun et al., 2009 ), 20,0 % (Dumelin, 2005 Braun et al., 2007) and 23,3 % (Jehle, 2004; Braun et al., 2006) . Other authors (Oetzel, 1988; Martig, 2002) reported recurrence rates ranging from 23 to 40 %. The recurrence rate was greater in group B than in group A (8 of 11 versus 3 of 11). It is possible that oral administration of sodium phosphate and calcium delayed the re-establishment of the calcium-phosphorus homeostasis. Only 11 of 30 cows (37 %) were cured of hypocalcaemia after a single treatment, which was considerably worse than cure rates previously reported at 46,7 % ( Braun et al., 2009 ), 66,0 % (Bostedt et al., 1979 ), 66,5 % (Lesch and Gelfert, 2006 ) and 73,5 % (Siegwart and Niederer, 2005 . The reason for the low single-treatment cure rate was not a lack of response to the initial treatment, but rather a relatively high recurrence rate. Thus, a reduction in the recurrence rate appears crucial for improving the single-treatment cure rate. The overall cure rate of 93,3 % was comparable with previous rates of 90 % (Salis, 2002; Braun et al., 2004a; Dumelin, 2005; Braun et al., 2007; Zulliger, 2008; Braun et al., 2009 ) and 97 % (Jehle, 2004; Braun et al., 2006) and also agreed with fi ndings that 5 to 10 % (Martig, 2002) and up to 14 % (Radostits et al., 2007) of cows with milk fever were euthanased because they did not respond to treatment. Electrolyte measurements confi rmed previous fi ndings of hypercalcaemia within the fi rst hour of treatment with return to the hypocalcaemic range after 5 hours, followed by the re-establishment of normocalcaemia after 72 hours (Dumelin, 2005; Braun et al., 2007; Zulliger, 2008; Braun et al., 2009) . The oral administration of calcium lactate to cows of group B was a novel adjunct to milk fever treatment, but it did not have an apparent effect on serum calcium concentration and did not prevent cows from becoming hypocalcaemic again. This was in agreement with recent observations that the oral administration of calcium lactate to healthy fresh cows does not cause an increase in the serum calcium concentration (Blatter, 2011) .
However, it contradicted observations by the inventors of the calcium lactate product who stated that it causes an increase in serum calcium when given to healthy fresh cows (Geishauser et al., 2008) . We selected calcium lactate rather than another oral calcium product because questions about its effi cacy had not yet surfaced.
The combined intravenous and oral administration of phosphorus resulted in normal phosphorus concentrations throughout the entire study period. This was not possible in earlier studies: the oral administration of 350 g sodium phosphate alone caused a slow increase in the serum phosphate concentration (Dumelin, 2005; Braun et al., 2007) , whereas the intravenous infusion of sodium phosphate alone caused only a temporary increase in the phosphate concentration (Zulliger, 2008; Braun et al., 2008) . Thus, because combined treatment has a rapid and prolonged effect on serum phosphorus concentration, this fi nding supports an earlier recommendation to add phosphorus to the milk fever treatment in cows with severe hypophosphataemia (Forrester and Moreland, 1989; Cheng et al., 1998; Visser't Hooft et al., 2005) . The high rate of recurrence at 8 hours after initial treatment for hypocalcaemia (70 %) was a major problem in this study. Compared with group A, the recurrence rate for hypocalcaemia was two times higher in group B. It is therefore not surprising that recurrence of milk fever was considerably higher in group B. Nel presente studio sono state trattate 15 mucche da latte affette da paresi puerperale per via endovenosa con 500 ml di una soluzione di boro gluconato di calcio al 40 % (gruppo A). Altre 15 mucche (gruppo B) anch'esse affette da paresi puerperale, hanno ricevuto lo stesso trattamento e una ulteriore somministrazione di 500 ml di bifosfato di sodio al 10 %, anche per via endovenosa. Inoltre, alle mucche del gruppo B sono stati somministrati 80 g di calcio dal lattato di calcio e 70 g di fosforo dal bifosfato di sodio per via orale. Successivamente per 72 ore sono stati prelevati campioni di sangue per la determinazione degli elettroliti. Tra i due gruppi non si sono segnalate differenze signifi cative in termini di progressione della malattia. In totale si sono guarite 14 mucche per gruppo. In entrambi i gruppi vi è stato un rapido e signifi cativo aumento della concentrazione di calcio. Dopodiché i livelli di calcio sono diminuiti lentamente ma in maniera costante. Il lattato di calcio somministrato per via orale non ha impedito la diminuzione dei livelli di calcio nel gruppo B e le curve di risposta del calcio tra i due gruppi non differivano in modo signifi cativo. Nel-rapidement juste après le traitement et atteignait son maximum après 20 minutes. Elle revenait ensuite lentement aux valeurs normales. Ces études prouvent que l'application combinée par voie intraveineuse et orale de phosphate de sodium chez des vaches souffrant de parésie puerpérale en suite d'une hypocalcémie et d'une hypophosphatémie rétablit rapidement et durablement le taux de phosphate sanguin. Contrairement à cela, il n'a pas été possible de stabiliser à long terme la calcémie dans un domaine normal. Malgré l'effet positif sur la phosphatémie, ce type de traitement n'a pas amélioré le succès thérapeutique.
le mucche del gruppo B, la concentrazione di fosfato inorganico ha subito un forte aumento subito dopo il trattamento e ha raggiunto il suo massimo dopo 20 minuti. Poi è diminuita lentamente fi no a valori normali. Le indagini mostrano che la somministrazione combinata endovenosa e orale di fosfato di sodio nelle mucche affette da paresi puerperale può aumentare rapidamente e in modo permanente i livelli di fosfato, in seguita a un'ipocalcemia e un'ipofosfatemia. A differenza delle concentrazioni di fosfato inorganico non si è riusciti a stabilizzare in modo permanente la concentrazione di calcio nei valori normali. Nonostante l'effetto positivo sul risultato nel contenuto sierologico di fosfato, questo approccio terapeutico non migliora il risultato del trattamento.
